BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 16500361)

  • 1. Beneficial effect of metformin on pregnancy outcome in women with polycystic ovary syndrome is not associated with major changes in C-reactive protein levels or indices of coagulation.
    Vanky E; Salvesen KA; Hjorth-Hansen H; Bjerve K; Carlsen SM
    Fertil Steril; 2006 Mar; 85(3):770-4. PubMed ID: 16500361
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Homocysteine levels are unaffected by metformin treatment in both nonpregnant and pregnant women with polycystic ovary syndrome.
    Carlsen SM; Kjøtrød S; Vanky E; Romundstad P
    Acta Obstet Gynecol Scand; 2007; 86(2):145-50. PubMed ID: 17364275
    [TBL] [Abstract][Full Text] [Related]  

  • 3. C-reactive protein levels are unaffected by metformin during pretreatment and an IVF cycle in women with polycystic ovary syndrome.
    Kjøtrød SB; Romundstad P; von Düring V; Sunde A; Carlsen SM
    Fertil Steril; 2008 Mar; 89(3):635-41. PubMed ID: 17548076
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of four different treatment regimens on coagulation parameters, hormonal and metabolic changes in women with polycystic ovary syndrome.
    Kebapcilar L; Taner CE; Kebapcilar AG; Alacacioglu A; Sari I
    Arch Gynecol Obstet; 2010 Jan; 281(1):35-42. PubMed ID: 19330342
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metformin reduces pregnancy complications without affecting androgen levels in pregnant polycystic ovary syndrome women: results of a randomized study.
    Vanky E; Salvesen KA; Heimstad R; Fougner KJ; Romundstad P; Carlsen SM
    Hum Reprod; 2004 Aug; 19(8):1734-40. PubMed ID: 15178665
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dietary intervention versus metformin to improve the reproductive outcome in women with polycystic ovarian syndrome.
    Kumar HK
    Saudi Med J; 2008 Apr; 29(4):625. PubMed ID: 18382816
    [No Abstract]   [Full Text] [Related]  

  • 7. Does continuous use of metformin throughout pregnancy improve pregnancy outcomes in women with polycystic ovarian syndrome?
    Nawaz FH; Khalid R; Naru T; Rizvi J
    J Obstet Gynaecol Res; 2008 Oct; 34(5):832-7. PubMed ID: 18834342
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The administration of metformin during pregnancy reduces polycystic ovary syndrome related gestational complications.
    De Leo V; Musacchio MC; Piomboni P; Di Sabatino A; Morgante G
    Eur J Obstet Gynecol Reprod Biol; 2011 Jul; 157(1):63-6. PubMed ID: 21530058
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of metformin in polycystic ovary syndrome: a meta-analysis.
    Creanga AA; Bradley HM; McCormick C; Witkop CT
    Obstet Gynecol; 2008 Apr; 111(4):959-68. PubMed ID: 18378757
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metformin in the treatment of clomiphene citrate-resistant women with polycystic ovary syndrome undergoing in vitro fertilisation treatment: a randomised controlled trial.
    Qublan HS; Al-Khaderei S; Abu-Salem AN; Al-Zpoon A; Al-Khateeb M; Al-Ibrahim N; Megdadi M; Al-Ahmad N
    J Obstet Gynaecol; 2009 Oct; 29(7):651-5. PubMed ID: 19757275
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of metformin on fat distribution and the metabolic syndrome in women with polycystic ovary syndrome--a randomised, double-blind, placebo-controlled trial.
    Lord J; Thomas R; Fox B; Acharya U; Wilkin T
    BJOG; 2006 Jul; 113(7):817-24. PubMed ID: 16827766
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metformin reduces abortion in pregnant women with polycystic ovary syndrome.
    Khattab S; Mohsen IA; Foutouh IA; Ramadan A; Moaz M; Al-Inany H
    Gynecol Endocrinol; 2006 Dec; 22(12):680-4. PubMed ID: 17162710
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevention of gestational diabetes by metformin plus diet in patients with polycystic ovary syndrome.
    Glueck CJ; Pranikoff J; Aregawi D; Wang P
    Fertil Steril; 2008 Mar; 89(3):625-34. PubMed ID: 17678910
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thrombin activatable fibrinolysis inhibitor and other hemostatic parameters in patients with polycystic ovary syndrome.
    Oral B; Mermi B; Dilek M; Alanoğlu G; Sütçü R
    Gynecol Endocrinol; 2009 Feb; 25(2):110-6. PubMed ID: 19253106
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Insulin-sensitizing agents and reproductive function in polycystic ovary syndrome patients.
    Palomba S; Falbo A; Orio F; Zullo F
    Curr Opin Obstet Gynecol; 2008 Aug; 20(4):364-73. PubMed ID: 18660688
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of metformin on early pregnancy loss in the polycystic ovary syndrome.
    Jakubowicz DJ; Iuorno MJ; Jakubowicz S; Roberts KA; Nestler JE
    J Clin Endocrinol Metab; 2002 Feb; 87(2):524-9. PubMed ID: 11836280
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Use of metformin in polycystic ovary syndrome].
    Carlsen SM
    Tidsskr Nor Laegeforen; 2009 Aug; 129(16):1644-6. PubMed ID: 19721481
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expanding applications for metformin in polycystic ovarian syndrome.
    Liu JH; Bill AH
    J Pediatr; 2006 May; 148(5):573-4. PubMed ID: 16737862
    [No Abstract]   [Full Text] [Related]  

  • 19. Neonatal outcome in polycystic ovarian syndrome patients treated with metformin during pregnancy.
    Kovo M; Weissman A; Gur D; Levran D; Rotmensch S; Glezerman M
    J Matern Fetal Neonatal Med; 2006 Jul; 19(7):415-9. PubMed ID: 16923696
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metformin effects on clomifene-induced ovulation in the polycystic ovary syndrome.
    Ben Ayed B; Dammak dit Mlik S; Ben Arab H; Trabelssi H; Chahtour H; Mathlouthi N; Dhuib M; Kassis M; Saiidane D; Trabelssi K; Guermazi M
    Tunis Med; 2009 Jan; 87(1):43-9. PubMed ID: 19522426
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.